Cargando...
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
The cluster-determinant 44 (CD44) receptor has a high affinity for hyaluronic acid (HA) binding and is a desirable receptor for active targeting based on its overexpression in cancer cells compared with normal body cells. The nanocarrier affinity can be increased by conjugating drug-loaded carriers...
Guardado en:
| Publicado en: | Drug Discov Today |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5413407/ https://ncbi.nlm.nih.gov/pubmed/28017836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2016.12.009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|